July 28, 2017Comments Off on Amgen gets fast FDA review for adding heart benefits to cholesterol drug label
(Reuters) – Amgen Inc said on Thursday the U.S. Food and Drug Administration granted priority review to the company’s request to add important heart safety data to the label of... Read More
July 15, 2017Comments Off on Novartis stocks drug cabinet with “Big-3” arthritis blockbusters
ZURICH (Reuters) – Switzerland’s Novartis is stocking up cheaper versions of the world’s top-selling arthritis medicines, hoping a broad portfolio gives it an edge on rivals with narrower offerings. Reuters:... Read More
July 10, 2017Comments Off on Shire gets injunction against Roche over hemophilia drug
ZURICH (Reuters) – Pharmaceutical group Shire said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche over its hemophilia drug emicizumab, alleging incomplete and... Read More
July 2, 2017Comments Off on Big pharma turns to AI to speed drug discovery, GSK signs deal
LONDON (Reuters) – The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $ 43 million... Read More
June 19, 2017Comments Off on New test may turn AZ’s Lynparza into precision drug for prostate cancer
LONDON (Reuters) – Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca’s drug Lynparza into a precision medicine for prostate cancer. Reuters: Health News... Read More
June 15, 2017Comments Off on Pfizer, Roche and Aspen face South African probe into cancer drug prices
PRETORIA (Reuters) – South Africa’s competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency’s chief said on Tuesday. Reuters: Health News... Read More
June 12, 2017Comments Off on Roche CEO still optimistic on new breast cancer drug
VIENNA (Reuters) – Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that disappointed analysts, the Swiss drugmaker’s... Read More
May 22, 2017Comments Off on Higher rate of heart problems seen with Amgen bone drug in trial
(Reuters) – Amgen Inc and UCB SA said on Sunday they did not expect their experimental osteoporosis drug to win U.S. approval this year after a higher rate of serious... Read More
May 17, 2017Comments Off on FDA warns of foot, leg amputations with J&J diabetes drug
(Reuters) – Johnson & Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration... Read More
May 11, 2017Comments Off on AstraZeneca asthma drug fails, after similar setback at Roche
(Reuters) – An experimental biotech drug for severe asthma from AstraZeneca failed to meet its goal of significantly reducing attacks in a late-stage study, dealing a blow to an approach... Read More
